Cystic Fibrosis: Clinical Phenotypes in Children and Adolescents
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The objective of this study was to describe the clinical phenotypes of children and adolescents with cystic fibrosis (CF); and to assess the role of pancreatic insufficiency and neonatal screening in diagnosis.Methods: A cross-sectional study was conducted, which included 77 patients attending a reference center of CF between 2014 and 2016. Epidemiological data, anthropometric measurements, and the presence of pulmonary, pancreatic, gastrointestinal and hepatobiliary manifestations were evaluated based on clinical data and complementary examinations.Results: Of the 77 patients, 51.9% were male, with a median age of 147 months (7.0-297.0 months), and the majority showed adequate nutritional status. The most common phenotype was pulmonary (92.2%), followed by pancreatic (87.0%), with pancreatic insufficiency in most cases. Gastrointestinal manifestation occurred in 46.8%, with constipation being the more common factor. Hepatobiliary disease occurred in 62.3% of patients. The group with pancreatic insufficiency was diagnosed earlier (5.0 months) when compared to the group with sufficiency (84.0 months) (p=0.01). The age of diagnosis was reduced following implementation of neonatal screening protocols for CF (6.0 months before vs. 3.0 months after, p=0.02).Conclusion: The pulmonary phenotype was the most common, although extrapulmonary manifestations were frequent and clinically relevant, and should mandate early detection and treatment. Neonatal screening for CF led to earlier diagnosis in patients with pancreatic failure, and therefore, should be adopted universally.
Abstract
Purpose: The objective of this study was to describe the clinical phenotypes of children and adolescents with cystic fibrosis (CF); and to assess the role of pancreatic insufficiency and neonatal screening in diagnosis.Methods: A cross-sectional study was conducted, which included 77 patients attending a reference center of CF between 2014 and 2016. Epidemiological data, anthropometric measurements, and the presence of pulmonary, pancreatic, gastrointestinal and hepatobiliary manifestations were evaluated based on clinical data and complementary examinations.Results: Of the 77 patients, 51.9% were male, with a median age of 147 months (7.0-297.0 months), and the majority showed adequate nutritional status. The most common phenotype was pulmonary (92.2%), followed by pancreatic (87.0%), with pancreatic insufficiency in most cases. Gastrointestinal manifestation occurred in 46.8%, with constipation being the more common factor. Hepatobiliary disease occurred in 62.3% of patients. The group with pancreatic insufficiency was diagnosed earlier (5.0 months) when compared to the group with sufficiency (84.0 months) (p=0.01). The age of diagnosis was reduced following implementation of neonatal screening protocols for CF (6.0 months before vs. 3.0 months after, p=0.02).Conclusion: The pulmonary phenotype was the most common, although extrapulmonary manifestations were frequent and clinically relevant, and should mandate early detection and treatment. Neonatal screening for CF led to earlier diagnosis in patients with pancreatic failure, and therefore, should be adopted universally.
참고문헌 (35)
- Kelly T, "Gastrointestinal manifestations of cystic fibrosis", Dig Dis Sci, 60, pp.1903~1913 (2015)[DOI]
- Gelfond D, "Gastrointestinal complications of cystic fibrosis", Clin Gastroenterol Hepatol, 11, pp.333~342 (2013)[DOI]
- Carvalho E, "Gastroenterologia e nutricao em pediatria" (2012), Manole
- Sathe MN, "Gastrointestinal, pancreatic, and hepatobiliary manifestations of cystic fibrosis", Pediatr Clin North Am, 63, pp.679~698 (2016)[DOI]
- Hurley MN, "Rate of improvement of CF life expectancy exceeds that of general population--observational death registration study", J Cyst Fibros, 13, pp.410~415 (2014)[DOI]
- Farrell PM, "Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report", J Pediatr, 153, pp.S4~S14 (2008)[DOI]
- [URL]
- Pereira CAC, "Espirometria", J Pneumol, 28(Suppl 3), pp.S1~S82 (2002)
- Lee TW, "Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients", J Cyst Fibros, 2, pp.29~34 (2003)[DOI]
- Moran A, "Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society", Diabetes Care, 33, pp.2697~2708 (2010)[DOI]
- Witt H, "Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy", Gastroenterology, 132, pp.1557~1573 (2007)[DOI]
- Vandenplas Y, "Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)", J Pediatr Gastroenterol Nutr, 49, pp.498~547 (2009)[DOI]
- Ciucă IM, "Cystic fibrosis liver disease - from diagnosis to risk factors", Rom J Morphol Embryol, 55, pp.91~95 (2014)
- [URL]
- [URL]
- Yadav K, "Evaluation of micronutrient profile of North Indian children with cystic fibrosis: a case-control study", Pediatr Res, 75, pp.762~766 (2014)[DOI]
- Rizzo LC, "Profile of cystic fibrosis in two reference centers in southern Brazil", Rev Assoc Med Bras (1992), 61, pp.150~155 (2015)[DOI]
- Del Ciampo IR, "Nutritional status of adolescents with cystic fibrosis treated at a reference center in the southeast region of Brazil", Ital J Pediatr, 41, pp.51~ (2015)[DOI]
- Goss CH, "Review: Staphylococcus aureus and MRSA in cystic fibrosis", J Cyst Fibros, 10, pp.298~306 (2011)[DOI]
- Elborn JS, "Cystic fibrosis", Lancet, 388, pp.2519~2531 (2016)[DOI]
- Simmonds NJ, "Cystic fibrosis in the 21st century", Respir Med, 24, pp.85~96 (2010)
- Munck A, "International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome", J Cyst Fibros, 15, pp.531~539 (2016)[DOI]
- Robinson NB, "Prevalence of gastroesophageal reflux in cystic fibrosis and implications for lung disease", Ann Am Thorac Soc, 11, pp.964~968 (2014)[DOI]
- Mousa HM, "Gastroesophageal reflux in cystic fibrosis: current understandings of mechanisms and management", Curr Gastroenterol Rep, 14, pp.226~235 (2012)[DOI]
- Gorter RR, "Clinical and genetic characteristics of meconium ileus in newborns with and without cystic fibrosis", J Pediatr Gastroenterol Nutr, 50, pp.569~572 (2010)
- El-Chammas KI, "Rectal prolapse and cystic fibrosis", J Pediatr Gastroenterol Nutr, 60, pp.110~112 (2015)[DOI]
- Ramos AF, "Cystic fibrosis, gastroduodenal inflammation, duodenal ulcer, and H. pylori infection: the "cystic fibrosis paradox" revisited", J Cyst Fibros, 12, pp.377~383 (2013)[DOI]
- Salvatore D, "Update of literature from cystic fibrosis registries 2012-2015. Part 6: Epidemiology, nutrition and complications", Pediatr Pulmonol, 52, pp.390~398 (2017)[DOI]
- Nascimento FS, "Hepatobiliary disease in children and adolescents with cystic fibrosis", J Pediatr (Rio J) (2017)
- Leeuwen L, "Liver disease in cystic fibrosis", Paediatr Respir Rev, 15, pp.69~74 (2014)
- Kobelska-Dubiel N, "Liver disease in cystic fibrosis", Prz Gastroenterol, 9, pp.136~141 (2014)
- Eminoglu TF, "Cystic fibrosis presenting with neonatal cholestasis simulating biliary atresia in a patient with a novel mutation", Indian J Pediatr, 80, pp.502~504 (2013)[DOI]
- Flass T, "Cirrhosis and other liver disease in cystic fibrosis", J Cyst Fibros, 12, pp.116~124 (2013)[DOI]
- Witters P, "Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease", Hepatology, 53, pp.1064~1065 (2011)[DOI]
- Witters P, "Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease", J Cyst Fibros, 8, pp.392~399 (2009)[DOI]